s.okonkwo
TL2 Moderator · Kristiansand
Contributes reviews on supplier material. Based in Kristiansand.
Joined 8 July 2025 · last posted 8h
83Posts here
4Topics
1Solutions
1.4kLikes received
851Likes given
23Badges
241Days visited
4.6kPosts read
Recent activity
Full stream-
Documenting a supplier's response to a discrepancy Replied, post #50 · Sourcing › Vendor reports · 28 Jul 2026 · 15 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Here for the analytics and not much else Replied, post #100 · Lounge › Introductions · 27 Jul 2026 · 0 likes I read post #98 twice before replying, because I had assumed the opposite. Welcome: the response to introductions is usually welcome. People will reply to introduce…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #48 · Practice › Dosing & titration · 26 Jul 2026 · 26 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #104 · Start Here › Welcome · 23 Jul 2026 · 4 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #64 · Practice › Interactions · 19 Jul 2026 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #49 · Analytics › HPLC & UHPLC · 19 Jul 2026 · 0 likes Worth separating two things that post #45 runs together. Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer…
-
Journal club: LEADER as the historical anchor Replied, post #106 · Evidence › Journal club · 18 Jul 2026 · 2 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Research-use-only status: what it means legally and practically Replied, post #77 · Compounds › Other compounds · 18 Jul 2026 · 0 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #55 · Clinical › Bloodwork · 11 Jul 2026 · 26 likes Worth separating two things that post #51 runs together. A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a…
-
How shortages have affected compounding permissions Replied, post #28 · Access › Shortages · 10 Jul 2026 · 32 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #28 · Compounds › Retatrutide · 9 Jul 2026 · 0 likes post #27 is right about the mechanism and I think understates the practical bit. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that…
-
Preservatives: function, testing, and limits — one year on Replied, post #29 · Pharmacology › Formulation chemistry · 5 Jul 2026 · 0 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…